AKANTO v KANTOS - is suggestive character subject to proof?

European Union

The EU General Court has confirmed that there was a likelihood of confusion between Novartis AG’s mark AKANTO and Chiesi Farmaceutici SpA’s earlier mark KANTOS for goods in Class 5.

Get unlimited access to all WTR content